ZURA

NASDAQ · Biotechnology

Zura Bio Ltd

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.01

+0.34 (+6.00%)

As of Feb 8, 1:58 PM ET ·

Income Statement

	FY 2025	FY 2024	FY 2023
Revenue	178.15M	170.40M	174.38M
Net Income	4.79M	4.86M	5.73M
EPS	—	—	—
Profit Margin	2.7%	2.9%	3.3%
Rev Growth	+24.5%	+6.4%	+20.2%

Balance Sheet

	FY 2025	FY 2024	FY 2023
Total Debt	64.32M	77.12M	80.74M
Total Equity	250.84M	225.49M	225.65M
D/E Ratio	0.26	0.34	0.36

Cash Flow

	FY 2025	FY 2024	FY 2023
EBITDA	8.96M	8.92M	9.38M
Free Cash Flow	5.34M	5.40M	5.82M